TrialAdvances in therapy2021

Comparative Efficacy of Cabozantinib and Ramucirumab After Sorafenib for Patients with Hepatocellular Carcinoma and Alpha-fetoprotein ≥ 400 ng/mL: A Matching-Adjusted Indirect Comparison.

Jörg Trojan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.